Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001306550-23-000580
Filing Date
2023-01-20
Accepted
2023-01-20 09:43:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 us04280a1007_011923.txt SC 13G 11701
  Complete submission text file 0001306550-23-000580.txt   13737
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-48710 | Film No.: 23539184
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies